Navigation Links
Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
Date:5/21/2012

BUFFALO, N.Y., May 21, 2012 /PRNewswire/ -- Kinex Pharmaceuticals, LLC and Xiangxue Pharmaceuticals announced today the execution of a license agreement from Kinex Pharmaceuticals granting Xiangxue Pharmaceuticals exclusive rights to KX02, for all oncology indications, in the greater China territory (China, Hong Kong, Taiwan) and Singapore.

KX02, a lipophilic dual src/pretubulin inhibitor, was discovered and developed by Kinex Pharmaceuticals through their internal R&D efforts. It is a small molecule that has shown potent inhibitory activity against a broad panel of brain tumor cell lines, including cells (T98G) that are resistant to Temodar, the most widely used chemotherapy for the treatment of malignant glioma. In a well-established brain tumor animal model, KX02 has been shown to consistently clear brain tumors after 4 weeks of therapy in 30-60% of treated animals. Pharmacokinetic studies showed that KX02 is absorbed orally  and has 76% penetration to brain tissue from plasma. Mechanistic studies showed that KX02 induced both surface and central necrosis of the glioma compared to Temodar which only induced surface necrosis. All preclinical studies, including toxicology studies in two animal species, essential for the filing of investigational new drug application (IND) to the US Food and Drug administration (FDA), have been completed. Kinex Pharmaceuticals is planning to file an IND in early third quarter of 2012 to initiate phase 1 clinical studies. The intellectual property of KX02 as a new chemical entity is protected by issued patents until February 2026.          

The acquisition of rights to develop drugs in certain Asian territories is part of Xiangxue Pharmaceuticals overall business strategy to expand their small molecule franchise, including their effort to work on new drug development, into those regions that have intellectual property protection. This strategy is in li
'/>"/>

SOURCE Kinex Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
2. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
3. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
6. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
7. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
8. Inovio Pharmaceuticals to Present at SPI 2012
9. Ampio Pharmaceuticals Schedules 2012 Update Webcast
10. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
11. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Does your doctor know what ... doctors have recommended marijuana to the over 112,000 currently registered ... the majority of the other roughly 20,300+ active physicians listed ... little about it – even though a poll in February ... say they have tried it. "With marijuana ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely eradicated ... generation ago are returning. Measles was declared eliminated in ... 2014 as of August 15—the highest incidence in 20 ... health department declared whooping cough a problem of ... getting sick and dying from these preventable diseases—in part ...
(Date:8/29/2014)... 29, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... Chief Executive Officer, will present at the CL King ... Tuesday, September 9, 2014 at 12:30 p.m. ET. The ... Hotel in New York City . ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... EyeScience(TM) ( www.eyescience.com ) announced today that ... and Dry Eye Formula(TM) are the only ... from their offices and through mass market retail. This announcement ... growing demand for the most complete eye vitamins available for ...
... (Nasdaq: HOLX ) today announced that Jack Cumming, Chairman, ... London on Tuesday, December 1, 2009, at 11:15am (GMT). ... audio webcast of Hologic,s investor presentation on the investor section ... An archive of the presentation will be available for replay ...
Cached Medicine Technology:EyeScience(TM) Announces New Program to Improve Patient Compliance and Practice Profits 2EyeScience(TM) Announces New Program to Improve Patient Compliance and Practice Profits 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Michigan’s health ... Affordable Care Act and the Healthy Michigan Plan. Throughout ... Komen remains a trusted funding resource for under-served individuals. ... assist uninsured or underinsured women between the ages of ... below 250 percent of the federal poverty level. ...
(Date:9/2/2014)... Plano, Texas (PRWEB) September 02, 2014 ... Expo, Prosupps will be an exhibitor at ... 3150 Paradise Rd, Las Vegas, NV 89109 Booth #374 ... vision is to encourage healthy living through exercise, diet ... to this vision, and provide the tools for all ...
(Date:9/2/2014)... Barcelona, Spain Tuesday 2 September 2014: Health ... heart failure guidelines, according to the results of ... Congress by Professor Aldo Maggioni. Clinical variables explained ... said: "This is a unique evaluation which combines ... countries. It provides a fuller picture of the ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Attorney Robert ... the 2015 "Lawyer of the Year" for Medical Malpractice ... & Meyer PC, Boston, and has been selected for inclusion ... Only one lawyer in each practice area and designated metropolitan ... on particularly impressive voting averages received during the peer-review assessments. ...
(Date:9/2/2014)... BC (PRWEB) September 02, 2014 ... pioneer in Canada announced today the expansion of its ... the company’s first Chief Financial Officer. Liang joins AURO ... Web Hosting, and will work closely with the operations, ... on expanding their cloud presence as well as ensuring ...
Breaking Medicine News(10 mins):Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 3Health News:Prosupps, One of the Fastest Growing Supplement Companies, Celebrates a Success Milestone with Exhibiting at the 50th Annual 2014 Mr. Olympia’s Fitness & Performance Expo 2Health News:Health structures explain nearly 20 percent of non-adherence to heart failure guidelines 2Health News:Robert Higgins Named 2015 Best Lawyers® "Lawyer of the Year" in Boston 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 3
... A new decades-long study launches today to investigate whether there ... long-term health problems such as cancer. The cohort study ... and Health Research (MTHR) Programme. The international study will run ... least 250,000 participants aged 18-69 in five European countries. The ...
... led by an Oregon Health & Science University Knight ... be used to help identify physicians who might ... Patricia A. Carney, Ph.D., OHSU School of Medicine professor ... Medicine; and associate director of Cancer Prevention, Control and ...
... ... EcoAdvisor for Earth Day. , ... Midland (PRWEB) April 22, 2010 -- In honour of Earth Day, OnlyGreen has planted 365 ... Mokugift, an official partner of the United Nations Environment Programme,s Plant for the Planet: Billion ...
... far most common choice of discipline , THURSDAY, April 22 ... American parents, but new research suggests it might still be ... conducted for C.S. Mott Children,s Hospital at the University of ... spank their child in some scenarios, said poll director Dr. ...
... ... ... management has come a long way in the last few decades. Advent of modern eye ... , ,We are excited though to tell about the latest technique Dr. Khanna is using ...
... ... LifeLinks innovative Spanish video interpreting services for the price of phone-only interpreting services. ... New York, ... breakthrough Spanish language interpretation. Pay the same for LifeLinks Spanish video interpretation service as ...
Cached Medicine News:Health News:Health impacts of mobile phone use to be explored in huge new study 2Health News:Health impacts of mobile phone use to be explored in huge new study 3Health News:Physicians who interpret mammograms may benefit from additional training 2Health News:Physicians who interpret mammograms may benefit from additional training 3Health News:OnlyGreen Plants 365 Trees for Earth Day 2010 2Health News:One in Five Parents Would Spank in Certain Settings 2Health News:One in Five Parents Would Spank in Certain Settings 3Health News:Glued graft for Pterygium Yield Better Cosmetic Results 2Health News:Glued graft for Pterygium Yield Better Cosmetic Results 3Health News:LifeLinks Revolutionizes Video Interpreting, Shows Spanish Interpreting in Added Dimension-VIDEO! 2
... ANA is an enzyme-linked immunosorbent assay (ELISA) ... (ANA) in human serum. The presence of ... clinical findings and other laboratory tests to ... such as systemic lupus erythematosus, Sjgren's syndrome, ...
The MESACUP ANA Test Kit is a semi-quantitative enzyme-linked immunosorbent assay,(ELISA) for the detection of specific anti-nuclear antibodies in human serum as an aid in,the determination of autoim...
... Immuno Concepts manufactures slides that are compatible ... to decrease the number of pipetting steps ... sample dilutions on the slides. Ask Immuno ... and these slides. These slide formats are ...
... HEp-2 cell line that has been genetically ... autoantibodies, without affecting the other ANA patterns ... worldwide on the HEp-2000 ANA substrate, which ... used in place of standard HEp-2 cells ...
Medicine Products: